Illumina Inc

Illumina Inc. develops manufactures and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables which include reagents flow cells and library preparation; and whole-genome sequencing kits which sequence entire genomes of any size and complexity and targeted resequencing kits which sequence exomes specific genes and RNA or other genomic regions of interest. Further it provides whole-genome sequencing genotyping NIPT and product support services; and Galleri a multi-cancer early detection test. The company serves genomic research centers academic institutions government laboratories and hospitals as well as pharmaceutical biotechnology commercial molecular diagnostic laboratories and consumer genomics companies. Further it markets and distributes its products directly to customers in North America Europe Latin America and the Asia-Pacific region as well as sells through life-science distributors in various markets within Europe the Asia-Pacific region Latin America the Middle East and Africa. Illumina Inc. was incorporated in 1998 and is headquartered in San Diego California.